| Financial Ratios | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 |
|---|---|---|---|---|
| Return on Equity | -99.235 | -36.052 | -34.616 | -23.399 |
| Net Profit Margin | -268.238 | -146.659 | -157.263 | -286.321 |
| Debt to Asset Ratio | 78.681 | 65.128 | 60.393 | 38.648 |
| Cash Ratio | 49.022 | 105.549 | 117.061 | 113.029 |
| Quick Ratio | 494.308 | 727.797 | 666.044 | 617.198 |
| Current Ratio | 494.308 | 727.797 | 666.044 | 617.198 |
ARS Pharmaceuticals, Inc. (SPRY)
ARS Pharmaceuticals, Inc. (SPRY)